BioCity Nottingham, Pennyfoot Street, Nottingham, NG1 1GF
t: +44 (0) 115 8880 406f: +44 (0) 115 8229345

News Articles

Every day counts: why pharmaceutical companies in the EU need to make sure they get the right SPC term

06 October 2011

SCRIP Regulatory Affairs October 2011, 6-7
Author: Mike Snodin

This article appeared in the October 2011 edition of SCRIP Regulatory Affairs. It argues that the standard practice of many national patent offices is incorrect, and that human medicinal products that are first authorised by the “centralised” (European Commission / European Medicines Agency) procedure should instead have SPC term calculated using the date of notification to the applicant of the European Commission's decision to issue a marketing authorisation. For some medicinal products this could lead to slightly longer (typically 2 to 4 days longer) SPC term.

We have placed cookies on your device to help make this website better. You can click the link below to disable cookies, otherwise, we'll assume you're happy to continue
Close This Notice

Disable Cookies | 3rd Party Data Processors